Q.One of the scientists working in the R&D laboratory of a major pharmaceutical company discovers that one of the company’s best-selling veterinary drugs has the potential to cure a currently incurable liver disease which is prevalent in tribal areas. However, developing a variant of the drug suitable for human being entailed a lot of research and development having a huge expenditure to the extent of Rs. 50 crores. It was unlikely that company would recover the cost as the disease was rampant only in poverty stricken areas having very little market otherwise. If you were the CEO, then A. Identify the various actions that you could take B. Evaluate the pros and cons of each of your actions
Model Answer
View this Question In PYQ RealmSyllabus Point
- Corporate Governance – Balancing corporate profits with social impact.
- Integrity in Public Administration – Making morally responsible leadership decisions.
- Probity in Governance – Ethical considerations in R&D investment & social good.
Introduction
The situation presents a classic ethical dilemma between corporate profitability and social responsibility. The discovery of a potential cure for a liver disease affecting impoverished tribal communities raises questions on corporate duty toward human welfare, especially when financial returns are unlikely. Corporate Social Responsibility (CSR), as per the Companies Act of India (2013), encourages companies to contribute to social development, although it may not legally bind them to pursue non-profitable ventures. However, the potential societal impact here is significant and merits thoughtful consideration.
Body Analysis
Stakeholders
- Pharmaceutical company and its shareholders
- Tribal communities affected by the liver disease
- Research and Development team
- Healthcare providers and NGOs working in tribal areas
- Government and health regulatory bodies
Actions Available as CEO
1. Invest in Developing the Drug Despite Financial Losses
Proceed with the research, testing, and production of the drug, ensuring its safety and effectiveness for human use, even if it is financially unprofitable.
- Pros:
- Aligns with the company’s ethical responsibilities and CSR objectives, enhancing the company's reputation and brand image.
- Positively impacts tribal communities, potentially saving numerous lives and contributing to public health.
- Cons:
- Financially burdensome with little to no direct returns, potentially affecting shareholder satisfaction.
- May limit resources for other R&D projects with higher financial returns.
2. Seek Government or NGO Collaboration and Funding
Approach the government, NGOs, or international health organizations for financial support or subsidies to offset development costs.
- Pros:
- Shared costs reduce the company’s financial burden, making it feasible to develop the drug without substantial losses.
- Government or NGO involvement could expedite approval processes and distribution channels, increasing reach and impact.
- Cons:
- Collaboration may introduce bureaucratic delays, slowing down development and distribution.
- Potential conflicts regarding control over pricing and distribution strategies.
3. License the Drug to Smaller or Non-Profit Pharmaceutical Companies
Transfer or license the drug technology to non-profit or smaller companies with social motives, allowing them to bear production costs and potentially provide the drug at affordable rates.
- Pros:
- Allows for drug development without significant investment from the company, fulfilling the social responsibility objective indirectly.
- Increases access to the drug for affected communities through a socially-driven entity with possibly lower production costs.
- Cons:
- The company may lose control over quality and distribution standards, potentially impacting brand reputation.
- May not yield any revenue, and could dilute the company’s innovation in the public eye.
4. Develop a Low-Cost Alternative with Limited Clinical Trials
Consider a more limited, cost-effective version of the drug with basic trials, intended specifically for emergency use in impoverished areas under conditional government approval.
- Pros:
- Reduces development costs substantially, making the initiative financially viable with lesser investment.
- Provides a solution that can be used in emergencies, particularly in underserved areas where alternatives are unavailable.
- Cons:
- Limited trials may raise ethical concerns regarding safety and efficacy, particularly if adverse effects arise.
- Conditional approval may restrict the drug’s distribution, limiting its availability and impact.
5. Abandon the Drug Development due to Financial Concerns
Decide not to pursue the development given the lack of financial return and refocus on profitable projects, prioritizing corporate sustainability.
- Pros:
- Maintains financial focus on profitable ventures, preserving shareholder interests and company sustainability.
- Prevents resource allocation to a low-return project, allowing the company to invest in other lucrative innovations.
- Cons:
- Ignores corporate social responsibility, potentially damaging the company’s public image.
- Fails to address a pressing public health need, which could lead to negative perceptions among stakeholders, including customers and employees.
Conclusion
The optimal approach would be a hybrid solution combining collaboration with government or NGOs and licensing to non-profit organizations. This approach balances the company's ethical obligations with its financial priorities, ensuring that tribal communities benefit from the drug without undue financial strain on the company. Such a solution also aligns with CSR values, building goodwill and enhancing the company's reputation in the long term. In the words of Mahatma Gandhi, "The best way to find yourself is to lose yourself in the service of others," which could guide corporate ethos in this case, allowing the company to pursue a socially impactful path without undermining its financial foundation.
